Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Dimethyltryptamine
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Appearance and form=== DMT is commonly handled and stored as a [[hemifumarate]],<ref name="TiHKAL">{{cite web|url=https://www.erowid.org/library/books_online/tihkal/tihkal06.shtml|title=Erowid Online Books: "TIHKAL" β #6 DMT|website=Erowid.org|access-date=2015-09-10|archive-date=2015-09-16|archive-url=https://web.archive.org/web/20150916005755/https://www.erowid.org/library/books_online/tihkal/tihkal06.shtml|url-status=live}}</ref><ref name="pmid32608093">{{cite journal | vauthors = Cozzi NV, Daley PF | title = Synthesis and characterization of high-purity ''N'',''N''-dimethyltryptamine hemifumarate for human clinical trials | journal = Drug Testing and Analysis | volume = 12 | issue = 10 | pages = 1483β1493 | date = October 2020 | doi = 10.1002/dta.2889| pmid = 32608093 | s2cid = 220290037 }}</ref> as other DMT acid salts are extremely [[Hygroscopy|hygroscopic]] and will not readily crystallize. Its [[Freebase (chemistry)|freebase]] form, although less stable than DMT hemifumarate, is favored by recreational users choosing to vaporize the chemical as it has a lower boiling point.<ref name="TiHKAL" /> DMT is a [[lipophilic]] [[chemical compound|compound]], with an experimental [[log P]] of 2.57.<ref name="Brito-da-CostaDias-da-SilvaGomes2020">{{cite journal | vauthors = Brito-da-Costa AM, Dias-da-Silva D, Gomes NG, Dinis-Oliveira RJ, Madureira-Carvalho Γ | title = Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N,N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact | journal = Pharmaceuticals (Basel) | volume = 13 | issue = 11 | date = October 2020 | page = 334 | pmid = 33114119 | pmc = 7690791 | doi = 10.3390/ph13110334 | doi-access = free | url = }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)